However, HER2+ BC with BrM is treated with surgery, whole brain radiotherapy, stereotactic radiosurgery, and chemotherapy, as well as earlier mentioned trastuzumab, pertuzumab, trastuzumab emtansine, lapatinib, and neratinib. The gene discussed is ERBB2; the disease is breast cancer.